Adaptilens

Series-A
adaptilens.com Biotech & Healthcare
Total Funding $20M
Latest Round Undisclosed Series-A
Last Announced May 11, 2026
Investors Undisclosed
Decision Makers Profile Active

About Adaptilens

The Adaptilens A-IOL recaptures the eye’s ability to accommodate by responding to its natural signal to focus without spectacle dependence.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website adaptilens.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $18,000,000 · Series-A

    startupintros.com

  3. Capital Raise

    Raised $2,000,000 · Seed

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Adaptilens.

Funding History

3 Rounds
Series-A equity · May 11, 2026
Series-A equity · Apr 1, 2024
Seed equity · Nov 1, 2020

Founders & Leadership

1

Liane Clamen

Founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts